Journal of Sasang Constitutional Medicine (사상체질의학회지)

The Society Of Sasang Constitutional Medicine (사상체질의학회)
권호 표지

Association Between Metabolic Syndrome and Adiponectin according to Sasang Constitution

사상체질에 따른 대사증후군과 Adiponectin의 상관성

  • Yu, Jun-Sang (Dept. of Sasang Constitutional Medicine, College of Oriental Medicine, Sangji University) ;
  • Koh, Sang-Baek (Dept of Preventive Medicine, Wonju College of Medicine, Yonsei University and Institute of Genomic Cohort) ;
  • Park, Jong-Ku (Dept of Preventive Medicine, Wonju College of Medicine, Yonsei University and Institute of Genomic Cohort)
  • 유준상 (상지대학교 한의과대학) ;
  • 고상백 (연세대학교 원주의과대학 예방의학교실 및 유전체코호트연구소) ;
  • 박종구 (연세대학교 원주의과대학 예방의학교실 및 유전체코호트연구소)
  • Received : 2009.10.15
  • Accepted : 2009.12.03
  • Published : 2009.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

1. Objectives: The objective of this study is to investigate the relationship between adiponectin and metabolic syndrome according to Sasang Constitution. 2. Methods: Six hundred sixty six participants were included in this cohort study. Sex, age, BMI(Body Mass Index), smoking, drinking, adiponectin level and Metabolic syndrome components were considerd. Sasang constitutional diagnosis was carried out by a sasang constitutional specialist using photos, questionnaires and PSSC(Phonetic System for Sasang Classification). 3. Results: In binary logistic analysis after adjustment of age, sex, BMI, smoking, drinking, adiponectin level and sasang constitution were related with Metabolic syndrome. 4. Conclusions: We suggest that adiponectin and sasang constitution are the important biomarker in Metabolic syndorme.

Keywords

Acknowledgement

Supported by : 상지대학교

References

  1. Ministry of Health and Welfare. Korean National Health and Nutrition Examination Survey(2005), Part 2. 2006:196.
  2. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program(NCEP) Adult Treat Panel III. JAMA. 2001;285:2486-2497. https://doi.org/10.1001/jama.285.19.2486
  3. Lee TG, Hwang MW, Lee SK, Choe BK, Song IB. A Study on the Prevalence and Risk Factors of the Metabolic Syndrome according to Sasang Constitution. J Korean Oriental Medicine. 2006;27(2):14-22. (Korean)
  4. Koh SB, Park JK, Yoon JH, Chang SJ, Oh SS, Kim JY, Ryu SY, Kim KS, Lee TY, Joshua H. You. A serious link between adiponectin levels and metabolic syndrome in a Korean nondiabetic population. Metabolism Clinical and Experimental. 2009. (Korean)
  5. Matsuzawa Y, Funahashi T, Kihara S, Shimomura I. Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004;24:29-33. https://doi.org/10.1161/01.ATV.0000099786.99623.EF
  6. Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB. Adiponectin—a key adipokine in the Metabolic syndrome. Diabetes Obes Metab. 2006;8:264-80. https://doi.org/10.1111/j.1463-1326.2005.00510.x
  7. World Health Organization Western Pacific Region International Obesity Task Force. The Asia-Pacific Perspective: redefining obesity and its treatment, Sydney: Health Communication Australia Pty Limited. 2000:20.
  8. Yang SM, Yoo JS, Koh SB, Park JK. Association between Risk Factors and Prevalence of Metabolic Syndrome According to Sasang Constitution in Wonju Cohort Study. J of Sasang Constitutional Medicine. 2009;21(1):186-196. (Korean)
  9. Szopa M, Malczewska-Malec M, Wybrańska I, Kiec-Wilk B. Variants of adiponectin gene as risk factors for the metabolic syndrome. Przegl Lek. 2009;66(5):257-62.